Google's Isomorphic Labs Raises $2.1B for AI Drug Discovery

Isomorphic Labs, Google DeepMind's drug discovery spinout led by Demis Hassabis, closed a $2.1B Series B to scale AI-driven biomedical research. The raise signals sustained institutional confidence in AlphaFold-era AI biology, positioning Isomorphic alongside Recursion and Insilico Medicine in the AI drug discovery race.